Fennec Pharmaceuticals GAAP EPS of -$0.02, revenue of $12.5M
Source: SeekingAlpha
2025-11-13 17:03:59 ET
More on Fennec Pharmaceuticals
- Fennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call Transcript
- Fennec Pharmaceuticals announces proposed offering of common shares
- Seeking Alpha’s Quant Rating on Fennec Pharmaceuticals
- Historical earnings data for Fennec Pharmaceuticals
- Financial information for Fennec Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Fennec Pharmaceuticals GAAP EPS of -$0.02, revenue of $12.5M
Fennec Pharmaceuticals Inc.
NASDAQ: FENC
FENC Trading
27.66% G/L:
$8.77 Last:
553,702 Volume:
$7.20 Open:
FENC Latest News
May 14, 2026 06:30:00 am
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 07, 2026 06:36:00 am
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
April 21, 2026 04:30:00 pm
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
FENC Stock Data
$217,266,422
14,266,721
89.84%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Research Triangle Park
